Pakistan, Aug. 7 -- Amazon Pharmacy has launched a new program to provide eligible Medicare patients with weight-loss medicines for $50 per month. The initiative aims to improve access to popular obesity treatments across the United States.

Read More: Asian markets sink with Wall St as tech firms take another hit

The company announced the service through the federal Medicare Bridge Program. The program began last month and will continue until the end of 2027. It allows eligible beneficiaries to receive approved weight-loss medicines at lower costs.

Patients can access medications from Novo Nordisk and Eli Lilly through the program. These include Wegovy in injection or pill form and Eli Lilly's Zepbound KwikPen. However, the program doe...